10.05.2022 - 12.05.2022Omni Parker House, 60 School Street, 02108 Boston, USA
Time: 09:00 - 15:30
Kongressthemen Maximize the Clinical and Commercial Opportunity of the Adenosine-Pathway as a Second-generation Immuno-oncology Target.
Adenosine-pathway therapies have produced a plethora of promising clinical trial data that is being met with refreshed excitement, enthusiasm, and R and D investment for adenosine-pathway targets.
Kongressorganizer (PCO) Hanson Wade
Anmerkungen Speakers: Arabella Young, Assistant Professor in the Department of Pathology; Investigator at the Huntsman Cancer Institute, The University of Utah, Bin Zhang, Professor, Northwestern University and more.